News & analysis on the clinical development and manufacture of large molecule drugs
Dispatches from Korea
Inside Celltrion: a biosimilar success story built on landfill
By Dan Stanton
- Last updated on
GMT
Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'
Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.
Eppendorf for Bioprocess – Solutions that grow with you | 29-Oct-2020
| Application Note
Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent...
Baxter BioPharma Solutions | 19-Oct-2020
| Technical / White Paper
The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...
Take the Right Path Upstream with MilliporeSigma | 20-Jul-2020
| Technical / White Paper
Strategies such as process intensification have the potential to create shorter lead times, reduce plant footprint, increase flexibility, and reduce COGs.
Take the Right Path Upstream with MilliporeSigma | 20-Jul-2020
| Technical / White Paper
This white paper describes process modeling and compares the process economics of a conventional upstream process versus three perfused seed train alternatives...
